1. Home
  2. ULCC vs LQDA Comparison

ULCC vs LQDA Comparison

Compare ULCC & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULCC
  • LQDA
  • Stock Information
  • Founded
  • ULCC 1994
  • LQDA 2004
  • Country
  • ULCC United States
  • LQDA United States
  • Employees
  • ULCC N/A
  • LQDA N/A
  • Industry
  • ULCC Air Freight/Delivery Services
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ULCC Consumer Discretionary
  • LQDA Health Care
  • Exchange
  • ULCC Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • ULCC 882.4M
  • LQDA 730.3M
  • IPO Year
  • ULCC 2021
  • LQDA 2018
  • Fundamental
  • Price
  • ULCC $3.74
  • LQDA $9.10
  • Analyst Decision
  • ULCC Hold
  • LQDA Strong Buy
  • Analyst Count
  • ULCC 11
  • LQDA 7
  • Target Price
  • ULCC $5.87
  • LQDA $25.50
  • AVG Volume (30 Days)
  • ULCC 1.6M
  • LQDA 1.9M
  • Earning Date
  • ULCC 10-24-2024
  • LQDA 11-05-2024
  • Dividend Yield
  • ULCC N/A
  • LQDA N/A
  • EPS Growth
  • ULCC N/A
  • LQDA N/A
  • EPS
  • ULCC N/A
  • LQDA N/A
  • Revenue
  • ULCC $3,612,000,000.00
  • LQDA $14,840,000.00
  • Revenue This Year
  • ULCC $7.19
  • LQDA N/A
  • Revenue Next Year
  • ULCC $16.95
  • LQDA $234.65
  • P/E Ratio
  • ULCC N/A
  • LQDA N/A
  • Revenue Growth
  • ULCC N/A
  • LQDA N/A
  • 52 Week Low
  • ULCC $2.79
  • LQDA $5.71
  • 52 Week High
  • ULCC $8.33
  • LQDA $16.99
  • Technical
  • Relative Strength Index (RSI)
  • ULCC 55.01
  • LQDA 35.13
  • Support Level
  • ULCC $3.53
  • LQDA $8.76
  • Resistance Level
  • ULCC $3.99
  • LQDA $9.87
  • Average True Range (ATR)
  • ULCC 0.17
  • LQDA 0.57
  • MACD
  • ULCC 0.08
  • LQDA -0.12
  • Stochastic Oscillator
  • ULCC 65.23
  • LQDA 41.96

About ULCC Frontier Group Holdings Inc.

Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: